secwatch.observer — SEC 8-K summary
======================================

Issuer:     SERA PROGNOSTICS, INC. (SERA)
CIK:        0001534969
Form:       8-K
Filed at:   2026-08-12T20:08:26+00:00
Accession:  0001193125-26-346846
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sera Q2 2026 net loss $9.1M; Illinois Medicaid mandates PreTRM coverage for 50K births
--------------------------------------------------------------------------------

- Q2 2026 revenue $30K vs $17K YoY; net loss $9.1M vs $8.0M; operating expenses $10.0M vs $9.3M.
- Illinois enacted law requiring Medicaid coverage for PreTRM test; covers ~50,000 annual Medicaid births.
- PRIME subgroup analysis: PreTRM cut NICU admissions 22% and severe neonatal morbidity 30% in first-time mothers.
- Launched fourth partnership program; payer discussions active in 20+ states; CE marking submission planned Q4 2026.
- Cash $80.3M; funds operations through 2029; Mark Capone added to board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534969/000119312526346846/0001193125-26-346846-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534969/000119312526346846/sera-20260812.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-346846

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer